Report Details
Contracted drug production - discover trends and segments with highest revenue potential

Where's outsourced pharma manufacturing heading? Visiongain's updated report predicts that industry's revenues from 2013. There you find potentials for sales growth, also understanding trends, technologies for drugs, clients' needs, and opportunities.

That study gives you revenue forecasts to 2023 at overall world market, submarket, and national level. Avoid falling behind, then. Instead see what's happening for those medical contracting services - outsourcing and off-shoring - finding how you can gain.

Read on to scan that industry and see what its future market could be worth.

Forecasts from 2013-2023 and other analyses show you the commercial prospects

Besides revenue forecasting to 2023, our new study shows you historical data, growth rates, and market shares. Hear, too, about developments in technology and service offerings. You also get 82 tables, 61 charts, and three interviews with leaders in companies.

Gains through understanding those outsourcing services - advantages for your work

Data searches can be hard work - all that looking. But now you can stay ahead in knowledge for contracted drug making, benefiting your research, analysis, and decisions. Finding information you need for producing medicines just got quicker and easier.

Use our predictions to help expand your business and give you more influence. You get the forecasting leaders need. So avoid falling behind, instead trying our new report now.

There you hear what's happening in the industry for contract manufacturing organisations (CMOs). You also see where needs and money exist, to 2023, finding the potential gains.

The following sections show how you benefit from that new investigation.

Forecasts from 2013 for the world market and submarkets for outsourced drug producing

What are the secrets of that industry's progress? Discover expected trends there. Along with prediction of the overall world market for out-contracting drug production, our report shows you revenue forecasting of 11 submarkets to 2023 at world level:
• Active pharmaceutical ingredients (APIs), with sub forecasts for generic APIs, high potency active pharma ingredients (HPAPIs), and related products
• Finished dosage formulations (FDFs), with sub forecasts for solid dose forms, injectable dosages, and other agents
• Other applications of outsourced production - other services
• Clinical manufacturing
• Commercial manufacturing.

Those analyses and discussions show you commercial potentials for manufacturing service providers and their technologies. Discover those money-gaining prospects.

You find geographical revenue predictions too.

National and regional markets - what outlooks for demand, service provision, and sales?

In developed and developing countries, opportunities for pharmaceutical CMOs will occur, often with rising potential. You see where and how.

Our analyses give individual revenue forecasts to 2023 for 12 national markets:
• United States (US)
• Japan
• EU leaders - Germany, France, the UK, Italy, and Spain (EU5), with an EU forecast
• BRIC countries - Brazil, Russia, India, and China
• South Korea.

There you hear about progress and outlooks. You find opportunity. Assess that medical production sector's future - hear about developments and find their significance.

See there what's likely to happen. Our work explains, exploring issues.

Developments, challenges, and opportunities affecting CMOs and clients

The report shows you activities and events affecting that industry and market from 2013, including these:
• Trends for investing in biopharma manufacturing
• Demands for formulation developing services
• Potential for microreactors in drug making
• EU re

Table Of Contents

1. Executive Summary

1.1 Pharma Contract Manufacturing: World Market Overview 2013
1.2 Report Contents
1.3 Research and Analysis Methods
1.4 An Introduction to Pharma Contract Manufacturing
1.4.1 Why Outsource in the Pharma Industry?
1.4.2 Services Offered by CMOs
1.4.3 Tactical and Strategic Manufacturing Outsourcing
1.4.4 Trends in Contract Manufacturing 2013-2023

2. The Pharma Contract Manufacturing Market: Outlook and Forecast 2013-2023

2.1 The Pharma Contract Manufacturing: Market Performance 2010-2012
2.1.1 Contract Manufacturing Is the Most Mature Pharma Outsourcing Sector
2.1.2 The Pharma Contract Manufacturing Market by Sector 2012
2.2 Pharma Contract Manufacturing: Overall Market Forecast 2013-2023
2.2.1 What Will Drive Growth for Contract Manufacturers 2013-2023?
2.2.2 Will Generics Drive or Restrain Market Growth in this Decade?
2.2.3 Outlook and Revenue Forecast for Other Contract Manufacturing Services 2013-2023
2.2.3.1 Rising Demand for Formulation Development Services
2.3 Clinical and Commercial Manufacturing Services
2.3.1 Clinical-Stage Manufacturing: Submarket Forecast 2013-2023
2.3.2 Commercial-Stage Manufacturing: Submarket Forecast 2013-2023
2.4 Leading Contract Manufacturing Organisations (CMOs) 2013
2.4.1 Catalent Pharma Solutions: The Market Leader
2.4.1.1 Expanding in Clinical and Biopharma Manufacturing
2.4.2 Lonza: An Expert in Biopharma Manufacturing
2.4.2.1 Lonza and Advanced Biopharma Manufacturing
2.4.3 Evonik Degussa: A Small Molecule Specialist
2.4.3.1 Growth in HPAPI Manufacturing
2.4.4 Royal DSM
2.4.4.1 Adding Biopharma Capacity
2.4.5 Teva API: The World's Largest API Manufacturer
2.4.5.1 Will Teva Expand in Emerging Markets?
2.4.6 Patheon
2.4.6.1 Patheon Is Adding New Formulation Development Services
2.4.7 Boehringer BioXcellence: Boehringer's Biopharma Manufacturing Division
2.4.7.1 Adding New Services for Growth
2.4.8 Famar
2.4.9 Fareva
2.4.10 Vetter Pharma: Aseptic Filling for Biologics and Small Molecules
2.4.10.1 Vetter Offers its Clients New Services

3. The Contract API Manufacturing Submarket: Outlook 2013-2023

3.1 The Contract API Manufacturing Submarket 2012
3.1.1 The API Manufacturing Submarket by Sector 2012
3.2 The Contract API Manufacturing Submarket Outlook 2013-2023
3.2.1 The Contract API Manufacturing Submarket Forecast 2013-2023
3.2.2 What Will Drive Submarket Growth to 2023?
3.2.2.1 The Potential for Microreactors in Commercial Manufacturing to 2023
3.2.3 How Will New EU Regulations Impact the API Manufacturing Submarket?
3.2.4 Contract API Manufacturing Submarket Restraints 2013-2023
3.2.4.1 Backwards Integration for Generics Manufacturers
3.3 The Contract Generic API Manufacturing Submarket 2013-2023
3.3.1 The Contract Generic API Manufacturing Submarket Forecast 2013-2023
3.3.2 The Contract Generic API Manufacturing Submarket Drivers and Restraints to 2023
3.3.2.1 The US Generic Drug User Fee Act and API Manufacturing
3.4 The Contract HPAPI Manufacturing Submarket 2013-2023
3.4.1 Challenges and Opportunities in High Containment Manufacturing
3.4.2 Many Companies Are Investing in HPAPI Manufacturing Facilities
3.4.3 The Contract HPAPI Manufacturing Submarket Forecast 2013-2023
3.4.4 Submarket Drivers and Restraints 2013-2023

4. The Contract FDF Manufacturing Submarket Outlook 2013-2023

4.1 The Contract FDF Manufacturing Submarket 2012
4.1.1 Solid Dosage Manufacturing Leads the Market
4.1.2 CMOs Report High Demand for Softgel Formulations
4.2 The Contract FDF Manufacturing Submarket Forecast 2013-2023
4.2.1 Complex Molecule Manufacturing Will Drive Growth to 2023
4.2.2 What Will Restrain Growth in FDF Outsourcing in this Decade?
4.3 The Contract Solid Dosage Manufacturing Submarket 2013-2023
4.3.1 How Will Revenues for

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

GRDSdata - subscription to industry data from across more than 100 industries and 90 countries

GRDSdata - subscription to industry data from across more than 100 industries and 90 countries

  • $ 26 587
  • Industry report
  • September 2014
  • by Global Research & Data Services

GRDSdata portal is a leading source of global industry information. This interactive platform provides you with unlimited and immediate access to invaluable market data from across more than 100 industries ...

Future Horizons and Growth Strategies in the Global Paint and Coatings Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Paint and Coatings Market 2014: Strategic Assessments of Leading Suppliers

  • $ 12 700
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $12,700.  Individual company assessments $2,450. This thought-provoking report on performance, capabilities, goals and strategies of the major competitors in the worldwide paints and coatings ...

Future Horizons and Growth Strategies in the Global Agrochemicals Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Agrochemicals Market 2014: Strategic Assessments of Leading Suppliers

  • $ 12 500
  • Industry report
  • August 2014
  • by Venture Planning Group

A strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, a task crucial to business survival, growth and profitability. Timely ...


2 Companies

Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.